Full text is available at the source.
Acrylamide aggravates cognitive deficits at night period via the gut–brain axis by reprogramming the brain circadian clock
Acrylamide worsens nighttime thinking problems by changing the gut-brain communication and brain’s internal clock
AI simplified
Abstract
ACR treatment in mice led to cognitive dysfunction and circadian disorder over 16 weeks.
- ACR induced a disruption of the circadian rhythm in the mice's brains.
- Cognitive dysfunction and spatial memory loss were more pronounced during the night phase.
- ACR treatment down-regulated key signaling pathways involved in cognitive function.
- An increase in excessive autophagy was observed in the hippocampus of ACR-treated mice during the night.
- ACR treatment triggered brain inflammation by compromising intestinal barrier integrity and elevating inflammatory markers.
AI simplified